IVERIC bio Inc.

NASDAQ: ISEE · Real-Time Price · USD
39.95
0.15 (0.38%)
At close: Jul 10, 2023, 10:00 PM

IVERIC bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
476.3M 261.45M
Short-Term Investments
170.53M 120.3M
Long-Term Investments
n/a n/a
Other Long-Term Assets
1.87M n/a
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
15.99M 5.74M
Total Current Assets
662.83M 387.49M
Property-Plant & Equipment
2.13M 1.87M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
4M 1.87M
Total Assets
666.82M 389.36M
Account Payables
22.84M 12.86M
Deferred Revenue
n/a n/a
Short-Term Debt
1.19M 952K
Other Current Liabilities
11.55M 14.4M
Total Current Liabilities
35.59M 28.21M
Long-Term Debt
96.58M 619K
Other Long-Term Liabilities
n/a n/a
Total Long-Term Liabilities
96.58M 619K
Total Liabilities
132.17M 28.83M
Total Debt
97.77M 1.57M
Common Stock
137K 115K
Retained Earnings
-864.81M -679.6M
Comprehensive Income
-229K -90K
Shareholders Equity
534.75M 360.5M
Total Investments
170.53M 120.3M